Friday 6 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue: +10.6%
EPS: −104.4%
Free cash flow: −69.3%
Total debt: +16.0%

Quarter to September 2026, against a year earlier

248.54 4.61 +1.89%

Follow BIIB

Alert me

Market cap: $36.1B
P/E: 104×
Fwd P/E: 47.4×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	19.93	19.61	38.04	95.71
P/S ratio Full definition →		2.61	2.72	3.18	3.24
P/FCF ratio Full definition →		12.77	11.24	12.56	19.70
P/Operating CF Full definition →		50.37	41.81	71.09	52.10
P/B ratio Full definition →		1.41	1.45	1.69	1.76
Price to Tangible BV Full definition →		9.97	8.68	0.00	0.00
EV/Sales Full definition →		2.86	2.92	3.78	3.82
EV/EBITDA Full definition →		9.62	9.57	14.71	17.20
EV/Operating CF Full definition →		12.82	11.19	13.17	17.52
EV/FCF Full definition →		13.99	12.07	14.93	23.24
Quick Ratio Full definition →		1.54	1.88	0.81	0.82
Current Ratio Full definition →		2.68	3.06	1.87	1.95
Net Debt/EBITDA Full definition →		5.84	2.83	10.18	10.57
Debt/Assets Full definition →		21.35%	21.33%	22.72%	22.75%
Debt/Equity Full definition →		0.34	0.34	0.39	0.39
Asset Turnover Full definition →		0.34	0.35	0.33	0.34
Operating CF/Net income Full definition →		(10.47)	2.02	4.60	(31.11)
Capex/Depreciation Full definition →		(0.19)	(0.16)	(0.40)	(0.61)
Research and Development Expense of Revenue Full definition →		22.35%	21.75%	19.36%	20.47%
Selling, General and Administrative Expense of Revenue Full definition →		29.94%	24.51%	25.94%	26.82%
Intangible Assets out of Total Assets Full definition →		0.53	0.53	0.64	0.64
Share Based Compensation of Revenue Full definition →		2.61%	3.39%	2.83%	2.91%
Graham Net Nets Full definition →		(0.09)	(0.06)	(0.19)	(0.17)
Graham Number Full definition →		157.35	163.27	127.71	82.45
Earnings Yield Full definition →		5.02%	5.10%	2.63%	1.04%
Free Cash Flow Yield Full definition →		7.83%	8.90%	7.96%	5.08%
Revenue per Share Full definition →		15.56	16.83	18.52	18.97
Operating CF per Share Full definition →		3.49	4.39	3.04	4.34
Capex per Share Full definition →		(0.41)	(0.35)	(1.19)	(1.80)
Free Cash Flow per Share Full definition →		3.08	4.04	1.85	2.54
Cash per Share Full definition →		26.05	29.09	8.70	8.82
Shareholders Equity per Share Full definition →		124.62	126.71	127.61	128.03
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		124.62	126.71	127.61	128.03
Free Cash Flow Full definition →		451.70	594.30	273.00	375.40
Working Capital Full definition →		5,624.70	6,191.50	3,388.60	3,686.00
Capital Expenditures Full definition →		(60.20)	(51.20)	(175.90)	(265.40)
Net Current Asset Value Full definition →		(2,208.60)	(1,641.00)	(5,932.90)	(5,547.60)
EV/EBIT Full definition →		15.17	15.42	30.63	50.80
Capex to Sales Full definition →		0.03	0.02	0.06	0.09
Price to Operating Income Full definition →		13.85	14.36	25.78	43.07
Other line items
Average Receivables Full definition →		1,373.60	1,682.85	1,754.90	1,629.35
Average Payables Full definition →		428.10	375.00	406.15	421.70
Average Inventory Full definition →		2,314.30	2,111.45	2,329.30	2,216.90
Average Assets Full definition →		28,744.40	28,758.10	30,208.40	30,630.80
Average Common Equity Full definition →		17,486.40	17,815.20	18,241.00	18,564.80

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly